Copyright
©The Author(s) 2023.
World J Gastrointest Endosc. Jun 16, 2023; 15(6): 447-457
Published online Jun 16, 2023. doi: 10.4253/wjge.v15.i6.447
Published online Jun 16, 2023. doi: 10.4253/wjge.v15.i6.447
Table 2 Frequencies and proportions of endoscopic ultrasound staging across pathological staging categories, n (%)
| Pathologic stage | ||||||
| T1a, N = 20 | T1b, N = 13 | T2, N = 5 | T3, N = 11 | |||
| EUS stage | T1a | n/N (%) | 17/20 (85.7) | 6/13 (46.2) | 1/5 (20) | 0/11 (0) |
| T1b | n/N (%) | 3/20 (14.2) | 6/13 (46.2) | 1/5 (20) | 0/11 (0) | |
| T2 | n/N (%) | 0/20 (0) | 1/13 (7.7) | 3/5 (60) | 0/11 (0) | |
| T3 | n/N (%) | 0/20 (0) | 0/13 (0) | 0/5 (0) | 11/11 (100) | |
- Citation: Kahlon S, Aamar A, Butt Z, Urayama S. Role of endoscopic ultrasound for pre-intervention evaluation in early esophageal cancer. World J Gastrointest Endosc 2023; 15(6): 447-457
- URL: https://www.wjgnet.com/1948-5190/full/v15/i6/447.htm
- DOI: https://dx.doi.org/10.4253/wjge.v15.i6.447